Back

South Korean biotech stocks diverge as Sky Labs surges 29.89% and Orum halves

Verifying
  • Sky Labs hit its price limit after joining TIME’s 2026 global health technology list.
  • 25,250 won marked Sky Labs’ close, a 29.89% gain from the previous session.
  • Orum plans to continue ORM-1153 development after BMS returned ORM-6151 rights.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
South Korean biotech stocks diverge as Sky Labs surges 29.89% and Orum halves - CoinPost Terminal